KR830008681A - 흡수량을 조절하는 엘라스타제 함유 조성물 - Google Patents

흡수량을 조절하는 엘라스타제 함유 조성물 Download PDF

Info

Publication number
KR830008681A
KR830008681A KR1019820000436A KR820000436A KR830008681A KR 830008681 A KR830008681 A KR 830008681A KR 1019820000436 A KR1019820000436 A KR 1019820000436A KR 820000436 A KR820000436 A KR 820000436A KR 830008681 A KR830008681 A KR 830008681A
Authority
KR
South Korea
Prior art keywords
fatty acid
elastase
sucrose fatty
containing composition
sucrose
Prior art date
Application number
KR1019820000436A
Other languages
English (en)
Other versions
KR880001808B1 (ko
Inventor
가즈오 다끼
료오이찌 마찌다
고오이찌 가다야마
Original Assignee
나이또오 유우지
에자이 가부시기 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나이또오 유우지, 에자이 가부시기 가이샤 filed Critical 나이또오 유우지
Publication of KR830008681A publication Critical patent/KR830008681A/ko
Application granted granted Critical
Publication of KR880001808B1 publication Critical patent/KR880001808B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

흡수량을 조절하는 엘라스타제 함유조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 위스터계 래트의 혈청엘라스타제 레벨곡선을 나타내고, 제2도는 비글개의 혈청엘라스타제 레벨 곡선을 나타낸다.

Claims (6)

  1. 순수 엘라스타제 1부당 슈크로스지방산 에스테르 0.5 내지 50부(중량) 함유한 엘라스타제 함유 조성물.
  2. 슈크로스 지방산 에스테르가 슈크로스 지방산 모노에스테르, 슈크로스 지방산 디에스테르, 슈크로서지방산 트리에스테르의 혼합물인 제1항의 엘라스타제 함유 조성물.
  3. 슈크로스지방산 에스테르 혼합물이 슈크로스 지방산 모노에스테르를 50%이상 함유하는 제2항의 엘라스타제 함유 조성물.
  4. 슈크로스 지방산에스테르 혼합물이 슈크로스 지방산 모노에스테르를 70%이상 함유하는 제3항의 엘라스타제 함유 조성물.
  5. 슈크로스지방산 에스테르가 탄소수 12-18의 지방산과 슈크로스를 함유하는 제1, 2, 3, 4, 5항의 엘라스타제 함유 조성물.
  6. 지방산이 스테아린산, 팔미틴산, 로린산, 올레인산으로 이루어지는 그룹에서 선택되는 제1, 2, 3, 4, 5항의 엘라스타제 함유 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR8200436A 1981-02-03 1982-02-03 엘라스타제 함유조성물의 제조방법 KR880001808B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56013754A JPS57128634A (en) 1981-02-03 1981-02-03 Elastase-containing compound increasing absorption
JP56-13754 1981-02-03

Publications (2)

Publication Number Publication Date
KR830008681A true KR830008681A (ko) 1983-12-14
KR880001808B1 KR880001808B1 (ko) 1988-09-19

Family

ID=11842034

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8200436A KR880001808B1 (ko) 1981-02-03 1982-02-03 엘라스타제 함유조성물의 제조방법

Country Status (8)

Country Link
US (1) US4397951A (ko)
EP (1) EP0057462B1 (ko)
JP (1) JPS57128634A (ko)
KR (1) KR880001808B1 (ko)
CA (1) CA1182747A (ko)
DE (1) DE3260589D1 (ko)
ES (1) ES509221A0 (ko)
PH (1) PH17715A (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208236A (ja) * 1982-05-28 1983-12-03 Eisai Co Ltd 糖尿病性腎症治療剤
JPS5951221A (ja) * 1982-09-17 1984-03-24 Eisai Co Ltd 変形性関節症治療剤
JPS61191610A (ja) * 1985-02-20 1986-08-26 Dai Ichi Kogyo Seiyaku Co Ltd 胃液中で速やかに溶解する錠剤
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
JPS6485660A (en) * 1987-02-19 1989-03-30 Nippon Medical Supply Suture coated with sugar fatty acid ester
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
HU205010B (en) * 1987-09-15 1992-03-30 Sandoz Ag Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
JPH02292226A (ja) * 1989-05-08 1990-12-03 Shigemi Fujisaki 障害された神経細胞賦活予防治療剤
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
WO2004052405A1 (en) * 2002-12-11 2004-06-24 Chong Kun Dang Pharmaceutical Corp. Oral formulations for poorly absorptive hydrophilic drugs
WO2006025882A2 (en) * 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US9114069B2 (en) * 2004-08-25 2015-08-25 Aegis Therapeutics, Llc Antibacterial compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US8642564B2 (en) * 2004-08-25 2014-02-04 Aegis Therapeutics, Llc Compositions for drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
TWI395593B (zh) * 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
AU2009228093B2 (en) * 2008-03-28 2014-08-07 Neurelis, Inc. Administration of benzodiazepine compositions
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
PL3415139T3 (pl) 2011-06-14 2022-07-11 Neurelis, Inc. Podawanie benzodiazepiny
CN105775051B (zh) * 2016-03-03 2017-08-11 上海船舶研究设计院 多功能油田增产作业支持船

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837444A (en) * 1956-10-26 1960-06-15 Armour & Co Improvements in and relating to the preparation of elastase
GB1076776A (en) * 1963-10-10 1967-07-19 Rolland Lab A Process for the extraction of elastase
GB1448276A (en) * 1973-09-15 1976-09-02 Eisai Co Ltd Elastase and methods for using same
JPS5261287A (en) * 1975-11-08 1977-05-20 Eisai Co Ltd Preparation of pancreatic elastase

Also Published As

Publication number Publication date
ES8502334A1 (es) 1985-01-01
KR880001808B1 (ko) 1988-09-19
EP0057462B1 (en) 1984-08-22
US4397951A (en) 1983-08-09
JPH0150686B2 (ko) 1989-10-31
EP0057462A3 (en) 1982-12-29
EP0057462A2 (en) 1982-08-11
PH17715A (en) 1984-11-19
CA1182747A (en) 1985-02-19
ES509221A0 (es) 1985-01-01
JPS57128634A (en) 1982-08-10
DE3260589D1 (en) 1984-09-27

Similar Documents

Publication Publication Date Title
KR830008681A (ko) 흡수량을 조절하는 엘라스타제 함유 조성물
KR830003571A (ko) 슈크로오스 에스테르를 함유하는 계면활성제의 제법
FI820275L (fi) Vaxdispersioner och deras anvaendning vid framstaellning av skvor och presskroppar
ATE13906T1 (de) Polyglycerinester enthaltende fette.
DE3062452D1 (en) Branched fatty acid cholesterol ester and a cosmetic composition containing the same
KR890016102A (ko) 안정화된 합성수지 조성물
FI823043A0 (fi) Vaotfraktionering av haerdat smoerfett
KR880007069A (ko) 트리글리세라이드 조성물
KR900001928A (ko) 종이 사이즈제
MX163526B (es) Esteres de interpolimeros que contienen carboxi
AU2065883A (en) Sulfur containing lubricating compositions
ES2064200B1 (es) Compuesto para la eliminacion de tintas.
GB2009768A (en) Stabilized Polyester Compositions
KR860004005A (ko) 디에스테르의 제조방법
KR890016151A (ko) 세제조성물
KR840000599A (ko) 내장재가 부착된 용기뚜껑 및 그 제법
KR910018493A (ko) 대전방지성 및 이온도전성 수지조성물
KR920007738A (ko) 저잔사 타잎 납땜 플럭스
KR890013164A (ko) 윤활유 조성물
KR870000279A (ko) 저장된 트리에틸렌디아민의 유동성 개량방법
GB1209501A (en) Ester lubricating oils
KR890008134A (ko) 브라씨노스테로이드 유도체 및 식물 성장 조절제
GB933505A (en) Synthetic lubricants
KR910015693A (ko) 금속가공용 윤활제 조성물
KR880006318A (ko) 변성된 폴리에스테르 수지 조성물